Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05116800
Title Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Brown University
Indications

leiomyosarcoma

rhabdomyosarcoma

synovial sarcoma

sarcoma

spindle cell sarcoma

myxofibrosarcoma

Ewing sarcoma

angiosarcoma

liposarcoma

malignant fibrous histiocytoma

osteosarcoma

Therapies

9-ING-41 + Docetaxel + Gemcitabine

Age Groups: senior | child | adult
Covered Countries USA


No variant requirements are available.